ClinicalTrials.Veeva

Menu

Testimonials and Navigation in Rheumatology (TANGO)

The University of Alabama at Birmingham logo

The University of Alabama at Birmingham

Status

Enrolling

Conditions

Rheumatologic Disease
Autoimmune Diseases

Treatments

Behavioral: Video comprised of AIRD patient narratives on COVID-19 vaccination thoughts and experiences
Behavioral: Video on the importance of good oral health for patients with AIRD
Behavioral: Brochure on the importance of good oral health in AIRD patients
Behavioral: Brochure on COVID-19 vaccination in AIRD patients
Behavioral: Patient Navigation

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06469788
IRB-300012168
5R01MD019235 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The overall goal of this study is to determine whether a novel, multi-modal, patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine.

Full description

Black and Latinx persons are at higher risk for certain autoimmune and inflammatory rheumatic diseases (AIRD) and have experienced worse COVID-19 outcomes compared to their white counterparts. Given the risks of severe COVID-19 outcomes such as hospitalization and death in people with AIRD, COVID-19 vaccine is recommended in this population. Historically, overall vaccine uptake among people with AIRDs has been low, and this vaccine reluctance has extended to COVID-19 vaccination. While additional COVID-19 vaccine doses have offered considerable added protection against severe outcomes, only 20% of all vaccinated persons in Alabama (AL) and 45% in Massachusetts have obtained an additional dose of COVID-19 vaccine as of October 2022. Racial and ethnic minority groups have faced disparities in obtaining subsequent COVID-19 vaccines, particularly in under-resourced communities, including those in Alabama and Massachusetts. Together, these obstacles exacerbate existing health inequities among people of color and perpetuate worse COVID-19 outcomes.

We will conduct a randomized controlled study to test an intervention that seeks to address gaps in COVID-19 vaccine information and access inequities common in Black and Latinx populations.

Enrollment

1,170 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults (18+ years) with known AIRD
  • Black race and/or Latinx ethnicity
  • Individuals who have not obtained the updated COVID-19 vaccine series (self-report)

Exclusion criteria

-Lack of access to phone

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

1,170 participants in 2 patient groups

"Storytelling" video including patient narratives, brochure and patient navigation
Experimental group
Description:
Participants will review video with narratives on COVID-19 vaccination in patients with AIRD, receive brochure on the same topic; and interact with patient navigators.
Treatment:
Behavioral: Patient Navigation
Behavioral: Brochure on COVID-19 vaccination in AIRD patients
Behavioral: Video comprised of AIRD patient narratives on COVID-19 vaccination thoughts and experiences
Attention Control: "Oral Health" video and "Oral Health" brochure
Active Comparator group
Description:
Participants will review video on the importance of oral health in patients with AIRD and receive brochure on the same topic.
Treatment:
Behavioral: Brochure on the importance of good oral health in AIRD patients
Behavioral: Video on the importance of good oral health for patients with AIRD

Trial contacts and locations

3

Loading...

Central trial contact

Paolo Rusconi, Project Director, PhD; Mary A Wilkenson, Clinical Research Coordinator, BS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems